Skip to content
drillr.ai
Sign up

CYTK

CYTOKINETICS INC

NASDAQ · Healthcare · Biotechnology · US

$62.65
+1.13%
Ask drillr
0
Insider buys (3m)
17
Insider sells (3m)
-$13.6M
Net value (3m)
-20.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 13, 2026Blum Robert I · director, officer: President & CEOM-Exempt7,500$11
Oct 13, 2026Blum Robert I · director, officer: President & CEOSale7,500$63
Oct 6, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentM-Exempt3,500$7.80
Oct 6, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentSale3,500$61
Sep 28, 2026Blum Robert I · director, officer: President & CEOM-Exempt7,500$11
Sep 28, 2026Blum Robert I · director, officer: President & CEOSale7,500$65
Sep 22, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentSale3,500$68
Sep 22, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentM-Exempt3,500$7.80
Sep 15, 2026Blum Robert I · director, officer: President & CEOSale97,926$69
Sep 15, 2026Blum Robert I · director, officer: President & CEOSale7,500$73
Sep 15, 2026Landry Robert E · directorSale1,000$72
Sep 15, 2026Blum Robert I · director, officer: President & CEOM-Exempt7,500$11
Sep 11, 2026Landry Robert E · directorSale1,000$75
Sep 8, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentM-Exempt3,500$7.80
Sep 8, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentSale3,500$75
Sep 1, 2026PARSHALL B LYNNE · directorSale5,000$71
Aug 31, 2026Callos Andrew · officer: EVP, Chief Commercial OfficerSale10,000$70
Aug 31, 2026Blum Robert I · director, officer: President & CEOSale7,500$70
Aug 31, 2026Callos Andrew · officer: EVP, Chief Commercial OfficerM-Exempt10,000$23
Aug 31, 2026Blum Robert I · director, officer: President & CEOM-Exempt7,500$11
Aug 18, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentM-Exempt3,500$7.80
Aug 18, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentSale3,500$76
Aug 10, 2026Blum Robert I · director, officer: President & CEOSale7,500$77
Aug 10, 2026Blum Robert I · director, officer: President & CEOM-Exempt7,500$11
Jul 30, 2026Callos Andrew · officer: EVP, Chief Commercial OfficerM-Exempt14,000$23
Jul 30, 2026Callos Andrew · officer: EVP, Chief Commercial OfficerSale14,000$80
Jul 27, 2026Blum Robert I · director, officer: President & CEOSale7,500$81
Jul 27, 2026Blum Robert I · director, officer: President & CEOM-Exempt7,500$11
Jul 23, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentM-Exempt3,500$7.80
Jul 23, 2026Malik Fady Ibraham · officer: EVP Research & DevelopmentSale3,500$81
Institutional positioning

13F filings over the trailing two quarters

New 170Increased 421Reduced 245Sold out 54
FilerActionSharesFiled
BlackRock, Inc.Increased20,094,362Aug 7, 2026
T. Rowe Price Investment Management, Inc.Increased18,718,498Aug 14, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Reduced17,523,840May 15, 2026
BLACKROCK, INC.Increased16,548,011May 13, 2026
FMR LLCReduced10,723,140May 15, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased8,009,489May 15, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced6,931,770Aug 14, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased6,711,799Aug 13, 2026
STATE STREET CORPIncreased6,494,233Sep 22, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased6,117,515Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position5,843,782May 8, 2026
STATE STREET CORPReduced5,745,193May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position5,488,634May 15, 2026
FMR LLCReduced5,031,782Aug 13, 2026
Avoro Capital Advisors LLCIncreased4,999,999Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 13, 2026